ViraWall is brought to you by Immunecology, Ltd., an innovator in the field of natural wellness. Immunecology is dedicated to developing extraordinary nutrients like ViraWall and supporting them with high quality scientific research. It is our goal to accurately describe our products and explain the science behind their potential benefits.

The development of ViraWall is based on sound science and rigorous laboratory evidence. ViraWall is not a drug. It is not intended to diagnose, prevent or treat illness. However, extensive laboratory testing has shown that the biologically active compounds in ViraWall can profoundly inhibit the entry of some viruses, including strains of the influenza (“flu”) virus, into cells. This is significant because viruses can only reproduce and cause problems after they gain entry into the living cells of our own bodies.

U.S. patent 6,346,408 was awarded based on the scientific demonstration of this virus blocking principle. Additional international patents protect the unique manufacturing process that ensures ViraWall’s extraordinary potency.

This links contained in this section, The Science of ViraWall, provide the reader with an introduction to viruses with a focus on influenza. It also describes research that has been conducted with ViraWall. Finally, there is a section where a variety of papers can be downloaded, including peer reviewed journal articles describing the properties of ViraWall’s primary active ingredient, phycocyanin.

At Immunecology, Ltd., we believe that quality information is the key to making conscious and informed choices about our own wellness. We are committed to an on-going process of education and research at the leading edges of natural health.

Educational Pages Understanding Viruses Understanding Influenza

ViraWall Research Pages ViraWall Flu Research

ViraWall Articles Effective Firewall Against the Flu traces the history of pandemic influenza and shows how ViraWall may help. A Powerful New Weapon in the Fight Against Flu outlines the impact of influenza on business and how ViraWall can be used as a strategic element of business planning. Dr. Kessler on ViraWall offers insight from a leading proponent of natural medicine about the importance of emerging viral threats and a possible role for ViraWall.

Technical Papers Journal of Medical Virology article highlights researching demonstrating the virus inhibiting effects of ViraWall’s primary active ingredient. Protein and Peptide Science article describes the anti-inflammatory and anti-oxidant properties of ViraWall’s primary active ingredient.

Subscribe to our news feed for automatic updates on ViraWall and our website.